03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Cisplatyl 25mg* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mediterranean Pharmaceutical Company |
Distributor | Mediterranean Pharmaceutical Company |
Laboratory | Sanofi |
Responsible Party | Bellon |
Origin | France |
Manufacturer | Bellon |
Origin | France |
ATC | L01XA01 |
Cisplatyl 25mg* :
Cisplatyl 25mg* :
Cisplatyl 25mg* :
Cisplatyl 25mg* :
Cisplatyl 25mg* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute leukaemia | Rare |
Alopecia | Not known |
Amylase increased | Not known |
Anaemia | Very Common |
Anaphylactoid reactions | Uncommon |
Anorexia | Not known |
Arrhythmia | Common |
Asthenia | Not known |
Blindness cortical | Not known |
Blood bilirubin increased | Not known |
Bone marrow failure (Myelosuppression) | Very Common |
Bradycardia | Common |
Cardiac arrest | Very rare |
Cardiac disorder | Not known |
Cerebral arteritis | Not known |
Cerebrovascular accident | Not known |
Colour blindness | Not known |
Convulsion | Rare |
Coombs test positive | Not known |
Cramp muscle | Not known |
Deafness | Not known |
Dehydration | Not known |
Diarrhoea (Diarrhea) | Not known |
Eruption | Not known |
Fever | Very Common |
Haemolytic anemia | Not known |
Haemolytic uraemic syndrome (HUS) | Not known |
Haemorrhagic stroke | Not known |
Hepatic enzyme increased | Not known |
Hiccups | Not known |
Hyperuricaemia | Not known |
Hypocalcaemia | Not known |
Hypokalaemia | Not known |
Hypomagnesaemia | Uncommon |
Hyponatraemia (Hyponatremia) | Very Common |
Hypophosphataemia | Not known |
Inappropriate antidiuretic hormone secretion (SIADH) | Not known |
Infection | Not known |
Injection site cellulitis | Not known |
Injection site erythema | Common |
Injection site extravasation | Not known |
Injection site fibrosis | Not known |
Injection site necrosis | Common |
Injection site oedema | Common |
Injection site pain | Common |
Ischaemic stroke | Not known |
Leucopenia (Leukopenia) | Very Common |
Leukoencephalopathy | Rare |
Lhermitte's sign | Not known |
Malaise | Not known |
Myelopathy | Not known |
Myocardial infarction | Rare |
Nausea | Not known |
Neuropathy | Not known |
Neuropathy peripheral | Rare |
Optic neuritis | Not known |
Ototoxicity | Uncommon |
Papilloedema | Not known |
Posterior reversible leukoencephalopathy syndrome (PRES) | Rare |
Pulmonary embolism | Not known |
Raynaud's phenomenon | Not known |
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Not known |
Renal insufficiency | Not known |
Renal tubular disorder | Not known |
Retinal pigmentation | Not known |
Sepsis (Systemic infection) (Sepsis state) | Common |
Spermatogenesis abnormal | Uncommon |
Stomatitis | Rare |
Tachycardia | Common |
Tetany | Not known |
Thrombocytopenic hemorrhage | Very Common |
Thrombotic microangiopathy | Not known |
Tinnitus | Not known |
Vision blurred | Not known |
Vomiting | Not known |
Cisplatyl 25mg* :
NB : Products With Same Indication |
Different Units By MoH Code
Cisplatyl 25mg* MoH 1784 :
Form | Solution for infusion |
Packaging | Bottle |
Package Size | 50ml |
Strength | 25mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 25042 |
Submission date | 01/01/1984 |
Registration Year | 1984 |
Archived Date | 2014 |
Price Comparison
● Country: | KSA | |
● Package Size: | 1 | |
● Public Price: | 57.7 SAR | ( 1,364,028.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 57,7 SAR | ( 1,347,480.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File